Your browser doesn't support javascript.
loading
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
McMellen, Alexandra; Yamamoto, Tomomi M; Qamar, Lubna; Sanders, Brooke E; Nguyen, Lily L; Ortiz Chavez, Daniela; Bapat, Jaidev; Berning, Amber; Post, Miriam D; Johnson, Joshua; Behbakht, Kian; Nurmemmedov, Elmar; Chuong, Edward B; Bitler, Benjamin G.
Afiliação
  • McMellen A; Cancer Biology Graduate Program, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Yamamoto TM; Department of Obstetrics & Gynecology, Division of Reproductive Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Qamar L; Department of Obstetrics & Gynecology, Division of Reproductive Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Sanders BE; Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Nguyen LL; Molecular Cellular Developmental Biology, The University of Colorado Boulder, Boulder, Colorado.
  • Ortiz Chavez D; Cancer Biology Graduate Program, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Bapat J; Cancer Biology Graduate Program, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Berning A; Department of Pathology, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Post MD; Department of Pathology, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Johnson J; Department of Obstetrics & Gynecology, Division of Reproductive Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Behbakht K; Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Nurmemmedov E; Saint John's Cancer Center, Los Angeles, California.
  • Chuong EB; Molecular Cellular Developmental Biology, The University of Colorado Boulder, Boulder, Colorado.
  • Bitler BG; Department of Obstetrics & Gynecology, Division of Reproductive Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Mol Cancer Res ; 21(1): 3-13, 2023 01 03.
Article em En | MEDLINE | ID: mdl-36149636
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article